4//SEC Filing
ENDRA Life Sciences Inc. 4
Accession 0001209191-17-039505
$NDRACIK 0001681682operating
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:43 PM ET
Size
5.4 KB
Accession
0001209191-17-039505
Insider Transaction Report
Form 4
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2017-06-09+31,960→ 31,960 totalExercise: $4.55Exp: 2022-05-12→ Common Stock (31,960 underlying)
Footnotes (1)
- [F1]These Stock Options become exercisable in three equal annual installments beginning on May 12, 2018.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001681682
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:43 PM ET
- Size
- 5.4 KB